These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 29403497)

  • 1. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cell-Specific Deletion of TRAIL Receptor Reveals Its Critical Role for Regulating Pathologic T Cell Activation and Disease Induction in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Chu CL; Hsu CL; Pan MH; Liao HJ; Wu CS; Hsu PN
    J Immunol; 2022 Apr; 208(7):1534-1544. PubMed ID: 35264458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE.
    Azcutia V; Bassil R; Herter JM; Engelbertsen D; Newton G; Autio A; Mayadas T; Lichtman AH; Khoury SJ; Parkos CA; Elyaman W; Luscinskas FW
    J Leukoc Biol; 2017 Feb; 101(2):493-505. PubMed ID: 27965383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
    Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
    J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
    Zhang L; Guo Y; Xia CQ
    J Immunol Res; 2015; 2015():129682. PubMed ID: 26258148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
    Kohm AP; Carpentier PA; Anger HA; Miller SD
    J Immunol; 2002 Nov; 169(9):4712-6. PubMed ID: 12391178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway.
    Chyuan IT; Tsai HF; Wu CS; Hsu PN
    Mucosal Immunol; 2019 Jul; 12(4):980-989. PubMed ID: 31076664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
    Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
    Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35-55-induced experimental autoimmune encephalomyelitis.
    Leuenberger T; Paterka M; Reuter E; Herz J; Niesner RA; Radbruch H; Bopp T; Zipp F; Siffrin V
    J Immunol; 2013 Nov; 191(10):4960-8. PubMed ID: 24123686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
    Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
    J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
    Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
    J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
    Gong Y; Wang Z; Liang Z; Duan H; Ouyang L; Yu Q; Xu Z; Shen G; Weng X; Wu X
    PLoS One; 2012; 7(10):e47435. PubMed ID: 23077616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.